Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

Index by author

March 01, 2017; Volume 42,Issue 2

Research

  • You have access
    Abstinence reverses EEG-indexed attention bias between drug-related and pleasant stimuli in cocaine-addicted individuals
    Muhammad A. Parvaz, Scott J. Moeller, Pias Malaker, Rajita Sinha, Nelly Alia-Klein and Rita Z. Goldstein
    J Psychiatry Neurosci March 01, 2017 42 (2) 78-86; DOI: https://doi.org/10.1503/jpn.150358
  • You have access
    Cognitive control deficit in patients with first-episode schizophrenia is associated with complex deviations of early brain development
    Olivier Gay, Marion Plaze, Catherine Oppenheim, Raphael Gaillard, Jean-Pierre Olié, Marie-Odile Krebs and Arnaud Cachia
    J Psychiatry Neurosci March 01, 2017 42 (2) 87-94; DOI: https://doi.org/10.1503/jpn.150267
  • You have access
    COMT Val158Met polymorphism moderates the association between PTSD symptom severity and hippocampal volume
    Jasmeet P. Hayes, Mark W. Logue, Andrew Reagan, David Salat, Erika J. Wolf, Naomi Sadeh, Jeffrey M. Spielberg, Emily Sperbeck, Scott M. Hayes, Regina E. McGlinchey, William P. Milberg, Mieke Verfaellie, Annjanette Stone, Steven A. Schichman and Mark W. Miller
    J Psychiatry Neurosci March 01, 2017 42 (2) 95-102; DOI: https://doi.org/10.1503/jpn.150339
  • You have access
    Cortical morphology as a shared neurobiological substrate of attention-deficit/hyperactivity symptoms and executive functioning: a population-based pediatric neuroimaging study
    Sabine E. Mous, Tonya White, Ryan L. Muetzel, Hanan El Marroun, Jolien Rijlaarsdam, Tinca J.C. Polderman, Vincent W. Jaddoe, Frank C. Verhulst, Danielle Posthuma and Henning Tiemeier
    J Psychiatry Neurosci March 01, 2017 42 (2) 103-112; DOI: https://doi.org/10.1503/jpn.150371
  • You have access
    Effects of dopaminergic genes, prenatal adversities, and their interaction on attention-deficit/hyperactivity disorder and neural correlates of response inhibition
    Dennis van der Meer, Catharina A. Hartman, Daan van Rooij, Barbara Franke, Dirk J. Heslenfeld, Jaap Oosterlaan, Stephen V. Faraone, Jan K. Buitelaar and Pieter J. Hoekstra
    J Psychiatry Neurosci March 01, 2017 42 (2) 113-121; DOI: https://doi.org/10.1503/jpn.150350
  • You have access
    Familial and environmental influences on brain volumes in twins with schizophrenia
    Marco M. Picchioni, Fruhling Rijsdijk, Timothea Toulopoulou, Christopher Chaddock, James H. Cole, Ulrich Ettinger, Ana Oses, Hugo Metcalfe, Robin M. Murray and Philip McGuire
    J Psychiatry Neurosci March 01, 2017 42 (2) 122-130; DOI: https://doi.org/10.1503/jpn.140277
  • You have access
    Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats
    Mason M. Silveira, Wendy K. Adams, Maria Morena, Matthew N. Hill and Catharine A. Winstanley
    J Psychiatry Neurosci March 01, 2017 42 (2) 131-138; DOI: https://doi.org/10.1503/jpn.150363

Psychopharmacology for the Clinician

  • You have access
    Generic formulations of psychotropic medications and treatment response
    Venkat Bhat and Howard C. Margolese
    J Psychiatry Neurosci March 01, 2017 42 (2) E3-E4; DOI: https://doi.org/10.1503/jpn.160004

Correction

  • You have access
    Correction: Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia
    J Psychiatry Neurosci March 01, 2017 42 (2) 102;
Back to top
PreviousNext

In this issue

Journal of Psychiatry and Neuroscience: 42 (2)
J Psychiatry Neurosci
Vol. 42, Issue 2
1 Mar 2017
  • Table of Contents
  • Index by author
Sign up for alerts
  • Most Read
  • Most Cited
  • Responses
Loading
  • Why is depression more prevalent in women?
  • The moving target of psychiatric diagnosis
  • Psychiatry is the flagship of personalized and precision medicine: proposing an epistemic horizon to biological psychiatry
  • Mindfulness-based treatments for posttraumatic stress disorder: a review of the treatment literature and neurobiological evidence
  • Factors influencing therapeutic effectiveness of electroencephalogram-based neurofeedback against core symptoms of ADHD: a systematic review and meta-analysis
More...

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire